• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. NEXIVA; PERIPHERAL IV CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. NEXIVA; PERIPHERAL IV CATHETERS Back to Search Results
Catalog Number 383512
Medical Device Problem Code Material Puncture/Hole (1504)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/09/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H.3.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.
 
Event or Problem Description
The flexible catheter is the part that bent.The needle appears to have punctured through it.The nurse said that she didn¿t do anything differently than insertions with these new ivs that she successfully placed.Customer responded on (b)(6) 2025 describe any patient harm, injury, complication or negative outcome that occurred as a result of the event.No injury to the patient.The iv insertion attempt had to be aborted, however, because the malfunction would not allow the nurse to advance the catheter.A second rn placed a different iv following the event.
 
Additional Manufacturer Narrative
The complaint of the needle puncturing the catheter was confirmed and the cause appeared to be associated with use.Two photographs were provided for investigation, which showed a needle protruding through the 22g nexiva iv catheter tubing.The tubing was bent at the puncture site.The sample exhibited evidence of use.Due to the presence of what appeared to be blood residue within the catheter tubing, it appeared that the device was able to access the vessel.The instructions for use (ifu) state, "if the needle is partially or completely withdrawn from the catheter tubing during insertion, do not re-insert the needle into the catheter tubing as damage may occur." no defects associated with the manufacturing process could be identified from the photograph.Manufacturing controls are in place to mitigate the occurrence of this type of failure.The complaint has been documented and will continue to be monitored as part of ongoing efforts to identify potential manufacturing related issues.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.
 
Event or Problem Description
No new information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEXIVA
Common Device Name
PERIPHERAL IV CATHETERS
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key23442223
Report Number1710034-2025-01712
Device Sequence Number15586877
Product Code FOZ
UDI-Device Identifier00382903835126
UDI-Public(01)00382903835126(11)250501(17)280430(10)5120903
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K183399
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Administrator/Supervisor
Type of Report Initial,Followup
Report Date (Section B) 12/09/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number383512
Device Lot Number5120903
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/13/2025
Supplement Date Received by Manufacturer12/09/2025
Initial Report FDA Received Date10/31/2025
Supplement Report FDA Received Date12/09/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/01/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-